CoChat

Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes

Morton, Adam · 2005 · The Journal of Clinical Endocrinology & Metabolism
Cited by 62

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

To the editor: Dhindsa et al. (1) recently described the frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes mellitus and the progressive fall in total, bioavailable, and free testosterone levels with increase in body mass index. They considered possible mechanisms including increased plasma levels of proinflammatory cytokines. Another practically important mechanism of hypogonadism in individuals with type 2 diabetes is obstructive sleep apnea (OSA). In one study (2), the prevalence of severe OSA in diabetic hypertensive men was 36%, significantly higher than the prevalence of 14.5% in normoglycemic hypertensive subjects. OSA is also associated with other insulin-resistant states, occurring 30 times more commonly in women with polycystic ovary syndrome than in matched controls (3). OSA is associated with hypogonadotropic hypogonadism, with improvements in testosterone levels after intervention with continuous positive airway pressure (CPAP) and surgery (4–6). CPAP treatment also improves insulin sensitivity (7). Dhindsa et al. also raise the question of testosterone replacement in hypogonadal men with type 2 diabetes, citing the need for prospective randomized trials to answer this question. Before entering such trials, it would be important that OSA be excluded as a cause of hypogonadism, not only because CPAP treatment may resolve their hypogonadism and symptoms, but also because exogenous testosterone may precipitate or aggravate OSA in susceptible individuals (8, 9). Hemochromatosis would also need to be excluded, given that it may be complicated by hypogonadotropic hypogonadism and type 2 diabetes mellitus.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2004-2310

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 62

Metadata

Authors
Morton, A.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2005-03
Volume
90
Issue
3
Pages
1903-1903
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2076458299
Cited by
62
References
5
FWCI
0.73
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes. https://app.cochat.ai/papers/10.1210/jc.2004-2310
The paper
Morton, A. (2005). Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2004-2310

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.